Mechanisms of Action: From Obesity to Addiction GLP-1 agonists enhance insulin secretion, slow gastric emptying, and promote satiety by acting on GLP-1 receptors in the hypothalamus and other brain regions involved in hunger regulation
What is AOD-9604 and How Does It Work
For those serious about understanding metabolic optimization at the deepest level, the cellular approach represented by 5-amino-1mq offers a compelling framework
Studies using radiolabeled BPC-157 show that even when injected in a distant location, the peptide migrates to injured tissues throughout the body
Since the approval of exenatide for the treatment of type 2 diabetes by the Food and Drug Administration (FDA) in 2005, research on GLP-1 RAs has become a hot topic and new analogs are constantly being introduced to the market
in one study, they saw improvements at 4 weeks, and even more at 8 weeks, so continuing for at least 2 months is advisable to judge benefit